Healthy participants study

This early-stage study tests an experimental drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's syndrome. The main goal is to check safety and how the body processes the drug. Researchers will also look for early signs that it might help co…

Researchers are testing an experimental oral drug called ALZ-507 in healthy adults aged 50 to 75. The study checks whether the drug is safe, what side effects it may cause, and how the body absorbs and clears it. Participants receive either ALZ-507 or a placebo, with some getting…

This early-stage trial is testing whether an experimental drug called ZP6590 is safe and how the body processes it. The study includes men with normal weight, overweight, and obesity. Some participants receive a single dose of ZP6590 or a placebo, while others receive multiple do…

This early-stage trial is testing an experimental tablet called ZL-65 in healthy adults aged 18 to 45. The main goal is to see if the drug is safe and tolerable when given as a single or multiple doses, and to learn how the body absorbs and processes it. The study also looks at w…

This study is the first time BY002 is being tested in humans. It aims to check the drug's safety and how the body processes it. Healthy adults will receive either BY002 or a placebo by injection. Researchers will monitor for side effects and measure drug levels in the blood.